Skip to main content
Fig. 1 | World Journal of Surgical Oncology

Fig. 1

From: A prospective, multicenter analysis of the integrated 31-gene expression profile test for sentinel lymph node biopsy (i31-GEP for SLNB) test demonstrates reduced number of unnecessary SLNBs in patients with cutaneous melanoma

Fig. 1

Love plot measuring the variance between patients enrolled in the current DECIDE study and those enrolled in the Whitman et al. report, who represent a non-overlapping cohort of patients treated primarily at surgical centers and for whom the 31-GEP was not used as part of the clinical SLNB decision process. T stage, age, and mitotic rate (MR) were included in the matching.

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us